Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 13Observational 1

Sponsor

Cancer Type

Dermatologic 38Thoracic 3Genitourinary 3Gastrointestinal 3Other solid neoplasm 2Lymphoid 2Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Sarcoma 219Osteosarcoma 91Bone Neoplasms 76Gastrointestinal Stromal Tumors 67Neoplasms 55Melanoma 41Sarcoma, Ewing 32Breast Neoplasms 31Lymphoma 30Dendritic Cell Sarcoma, Interdigitating 27Leukemia 25Stomach Neoplasms 23Sarcoma, Kaposi 23Prostatic Neoplasms 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Brain Neoplasms 22Uterine Cervical Neoplasms 20Pancreatic Neoplasms 20Ovarian Neoplasms 20Neuroblastoma 20Esophageal Neoplasms 20Central Nervous System Neoplasms 20Lymphoma, Non-Hodgkin 18Lung Neoplasms 18Glioblastoma 18Desmoid Tumors 18Rhabdomyosarcoma 17Colorectal Neoplasms 17Colonic Neoplasms 17Multiple Myeloma 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Uveal Melanoma × Sarcoma × Clear all
NCT05812027 2025-11-17

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

TScan Therapeutics, Inc.

Active not recruiting
1,150 enrolled
DermatologicGynecologicHead & NeckSarcomaThoracic

Uveal Melanoma, Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡